Russell Investments Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Buy |
283,741
+67,037
| +31% | +$2.89M | 0.02% | 766 |
|
|
2025
Q1 | $7.49M | Buy |
216,704
+212,630
| +5,219% | +$7.35M | 0.01% | 951 |
|
|
2024
Q4 | $112K | Sell |
4,074
-860
| -17% | -$23.6K | ﹤0.01% | 2664 |
|
|
2024
Q3 | $126K | Buy |
4,934
+4,410
| +842% | +$112K | ﹤0.01% | 2602 |
|
|
2024
Q2 | $13.3K | Sell |
524
-46,824
| -99% | -$1.19M | ﹤0.01% | 3024 |
|
|
2024
Q1 | $1.46M | Buy |
47,348
+44,788
| +1,750% | +$1.38M | ﹤0.01% | 1815 |
|
|
2023
Q4 | $103K | Buy |
2,560
+2,452
| +2,270% | +$99K | ﹤0.01% | 2550 |
|
|
2023
Q3 | $2.85K | Buy |
108
+15
| +16% | +$396 | ﹤0.01% | 3222 |
|
|
2023
Q2 | $1.6K | Sell |
93
-800
| -90% | -$13.8K | ﹤0.01% | 3274 |
|
|
2023
Q1 | $14.8K | Sell |
893
-116,267
| -99% | -$1.93M | ﹤0.01% | 2845 |
|
|
2022
Q4 | $893K | Sell |
117,160
-206,036
| -64% | -$1.57M | ﹤0.01% | 2033 |
|
|
2022
Q3 | $3.21M | Buy |
323,196
+87,439
| +37% | +$868K | 0.01% | 1295 |
|
|
2022
Q2 | $2.14M | Buy |
235,757
+78,359
| +50% | +$711K | ﹤0.01% | 1552 |
|
|
2022
Q1 | $1.6M | Buy |
157,398
+39,083
| +33% | +$397K | ﹤0.01% | 1739 |
|
|
2021
Q4 | $1.97M | Sell |
118,315
-9,841
| -8% | -$164K | ﹤0.01% | 1815 |
|
|
2021
Q3 | $6.01M | Buy |
128,156
+5,411
| +4% | +$254K | 0.01% | 1144 |
|
|
2021
Q2 | $7.48M | Buy |
122,745
+91,202
| +289% | +$5.56M | 0.01% | 1092 |
|
|
2021
Q1 | $1.94M | Sell |
31,543
-4,726
| -13% | -$291K | ﹤0.01% | 1887 |
|
|
2020
Q4 | $2.58M | Sell |
36,269
-6,680
| -16% | -$475K | 0.01% | 1622 |
|
|
2020
Q3 | $1.61M | Buy |
42,949
+8,397
| +24% | +$315K | ﹤0.01% | 1824 |
|
|
2020
Q2 | $1.13M | Buy |
+34,552
| New | +$1.13M | ﹤0.01% | 1986 |
|